Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2016-12-21

FDA Approved: DAPTOMYCIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved the supplemental application for daptomycin by Hikma Pharmaceuticals USA Inc., resulting in changes to the labeling and potential updates to indica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Daptomycin (daptomycin)

Snippet

SUPPL AP for DAPTOMYCIN (DAPTOMYCIN)